Pirenzepine in peptic ulcer. Introduction to clinical trials reports.
The main pharmacodynamic characteristics of pirenzepine are briefly reported and the experimental plan of the clinical trial on pirenzepine in peptic ulcer is discussed.
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D010890:Pirenzepine
D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D010879:Piperazines; D010890:Pirenzepine; D001285:Atropine